Medicamen Biotech standalone net profit rises 61.74% in the March 2018 quarter

Sales rise 31.51% to Rs 29.30 crore

Net profit of Medicamen Biotech rose 61.74% to Rs 1.86 crore in the quarter ended March 2018 as against Rs 1.15 crore during the previous quarter ended March 2017. Sales rose 31.51% to Rs 29.30 crore in the quarter ended March 2018 as against Rs 22.28 crore during the previous quarter ended March 2017.

For the full year,net profit rose 95.93% to Rs 10.11 crore in the year ended March 2018 as against Rs 5.16 crore during the previous year ended March 2017. Sales rose 35.23% to Rs 111.51 crore in the year ended March 2018 as against Rs 82.46 crore during the previous year ended March 2017.

 

ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales29.3022.28 32 111.5182.46 35 OPM %12.9014.63 -14.7813.34 - PBDT4.272.07 106 15.968.28 93 PBT3.771.57 140 13.906.36 119 NP1.861.15 62 10.115.16 96

Powered by Capital Market - Live News